Paper37185136
Preclinical evaluation of ZL006-05, a new antistroke drug with fast-onset antidepressant and anxiolytic effects.
Wu H and 15 others. Stroke Vasc Neurol, 2023. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Preclinical evaluation of ZL006-05, a new antistroke drug with fast-onset antidepressant and anxiolytic effects. Papers, record 37185136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37185136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Preclinical evaluation of ZL006-05, a new antistroke drug with fast-onset antidepressant and anxiolytic effects.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Anxiety Agents | Major topic |
| Stroke | Major topic |
| Rats | |
| Mice | |
| Animals | |
| Antidepressive Agents | |
| Brain | |
| Anxiety |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06770491 | A Phase 1 Study of Y-3 in US Healthy Volunteers. | Results |
Source ClinicalTrials.gov
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25904764 | Post-ischaemic silencing of p66Shc reduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke. | Eur Heart J | 2015 | https://conductscience.org/library/papers/25904764 | PubMed |
| 2 | 21613472 | Hippocampal neuronal nitric oxide synthase mediates the stress-related depressive behaviors of glucocorticoids by downregulating glucocorticoid receptor. | J Neurosci | 2011 | https://conductscience.org/library/papers/21613472 | PubMed |
| 3 | 34936876 | Stepwise disassembly of GABAergic synapses during pathogenic excitotoxicity. | Cell Rep | 2021 | https://conductscience.org/library/papers/34936876 | PubMed |
| 4 | 34780067 | Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. | Cochrane Database Syst Rev | 2021 | https://conductscience.org/library/papers/34780067 | PubMed |
| 5 | 33897893 | A pain killer without analgesic tolerance designed by co-targeting PSD-95-nNOS interaction and α2-containning GABAARs. | Theranostics | 2021 | https://conductscience.org/library/papers/33897893 | PubMed |
| 6 | 29988104 | Sucrose preference test for measurement of stress-induced anhedonia in mice. | Nat Protoc | 2018 | https://conductscience.org/library/papers/29988104 | PubMed |
| 7 | 26732589 | Downregulation of GABAA Receptor Recycling Mediated by HAP1 Contributes to Neuronal Death in In Vitro Brain Ischemia. | Mol Neurobiol | 2017 | https://conductscience.org/library/papers/26732589 | PubMed |
| 8 | 18512761 | Neuroprotection of gamma-aminobutyric acid receptor agonists via enhancing neuronal nitric oxide synthase (Ser847) phosphorylation through increased neuronal nitric oxide synthase and PSD95 interaction and inhibited protein phosphatase activity in cerebral ischemia. | J Neurosci Res | 2008 | https://conductscience.org/library/papers/18512761 | PubMed |
| 9 | 25129479 | CAPON-nNOS coupling can serve as a target for developing new anxiolytics. | Nat Med | 2014 | https://conductscience.org/library/papers/25129479 | PubMed |
| 10 | 32179262 | Post-stroke depression and functional impairments - A 3-year prospective study. | Compr Psychiatry | 2020 | https://conductscience.org/library/papers/32179262 | PubMed |
| 11 | 24899700 | Neuronal nitric oxide synthase-dependent S-nitrosylation of gephyrin regulates gephyrin clustering at GABAergic synapses. | J Neurosci | 2014 | https://conductscience.org/library/papers/24899700 | PubMed |
| 12 | 33588596 | Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke: A Phase III, Randomized, Double-Blind, Comparative Trial. | Stroke | 2021 | https://conductscience.org/library/papers/33588596 | PubMed |
| 13 | 20690858 | Depression in acute stroke: prevalence, dominant symptoms and associated factors. A systematic literature review. | Disabil Rehabil | 2011 | https://conductscience.org/library/papers/20690858 | PubMed |
| 14 | 32765326 | Admission Heart Rate Variability Is Associated With Poststroke Depression in Patients With Acute Mild-Moderate Ischemic Stroke. | Front Psychiatry | 2020 | https://conductscience.org/library/papers/32765326 | PubMed |
| 15 | 28592694 | Opening a New Time Window for Treatment of Stroke by Targeting HDAC2. | J Neurosci | 2017 | https://conductscience.org/library/papers/28592694 | PubMed |
| 16 | 21799515 | Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes. | Nat Rev Drug Discov | 2011 | https://conductscience.org/library/papers/21799515 | PubMed |
| 17 | 30727847 | Dissociating nNOS (Neuronal NO Synthase)-CAPON (Carboxy-Terminal Postsynaptic Density-95/Discs Large/Zona Occludens-1 Ligand of nNOS) Interaction Promotes Functional Recovery After Stroke via Enhanced Structural Neuroplasticity. | Stroke | 2019 | https://conductscience.org/library/papers/30727847 | PubMed |
| 18 | 33234346 | Regulation of GABAARs by Transmembrane Accessory Proteins. | Trends Neurosci | 2021 | https://conductscience.org/library/papers/33234346 | PubMed |
| 19 | 30184240 | Anxiety after stroke: A systematic review and meta-analysis. | J Rehabil Med | 2018 | https://conductscience.org/library/papers/30184240 | PubMed |
| 20 | 21102461 | Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95. | Nat Med | 2010 | https://conductscience.org/library/papers/21102461 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42226217 | Microbiota, systemic immunity, and extracellular vesicles in stroke: peripheral nodes as therapeutic leverage points. | J Neuroinflammation | 2026 | https://conductscience.org/library/papers/42226217 | PubMed |
| 41730997 | A modified tail suspension test for the assessment of behavioral despair in mice after stroke. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/41730997 | PubMed |
| 41652153 | Neuropsychiatric drug development in China: Current status and emerging trends. | Mol Psychiatry | 2026 | https://conductscience.org/library/papers/41652153 | PubMed |
| 41344725 | Loberamisal for Acute Ischaemic Stroke (LAIS): a multicentre, randomised, double-blind, parallel, placebo-controlled phase III clinical trial. | Stroke Vasc Neurol | 2026 | https://conductscience.org/library/papers/41344725 | PubMed |
| 41218852 | Loberamisal injection for the treatment of acute ischaemic stroke: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial. | Stroke Vasc Neurol | 2026 | https://conductscience.org/library/papers/41218852 | PubMed |
| 41202125 | DKK3-LRP1 complex and a chemical inhibitor regulate Aβ clearance in models of Alzheimer's disease. | Sci Adv | 2025 | https://conductscience.org/library/papers/41202125 | PubMed |
| 40461153 | Efficacy and safety of Y-3 intracalvariosseous injection versus intravenous injection in the treatment of acute large hemispheric infarction (SOLUTION-2): rationale and design of a multicentre, prospective, randomised, open-label, blind endpoint (PROBE) trial. | Stroke Vasc Neurol | 2026 | https://conductscience.org/library/papers/40461153 | PubMed |
| 39884187 | Intracalvariosseous injection: an approach for central nervous system drug delivery through skull bone marrow with a preclinical research in stroke. | EBioMedicine | 2025 | https://conductscience.org/library/papers/39884187 | PubMed |
| 39126054 | Advancements in the Research of New Modulators of Nitric Oxide Synthases Activity. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39126054 | PubMed |
| 37832977 | Reperfusion and cytoprotective agents are a mutually beneficial pair in ischaemic stroke therapy: an overview of pathophysiology, pharmacological targets and candidate drugs focusing on excitotoxicity and free radical. | Stroke Vasc Neurol | 2024 | https://conductscience.org/library/papers/37832977 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| DLG4 | 1742 | PubTator's text mining | https://conductscience.org/library/genes/1742 | NCBI Gene |
| NOS1 | 4842 | PubTator's text mining | https://conductscience.org/library/genes/4842 | NCBI Gene |
| PLAT | 5327 | PubTator's text mining | https://conductscience.org/library/genes/5327 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37185136
GET https://conductscience.org/api/papers/v1/37185136/references?page=2